Factors associated with COVID-19-related death using OpenSAFELY

Williamson, Elizabeth J., Walker, Alex J., Bhaskaran, Krishnan, Bacon, Seb, Bates, Chris, Morton, Caroline E., Curtis, Helen J., Mehrkar, Amir +22 more·2020·Nature
DOI 10.1038/s41586-020-2521-4

Cited by (1,015)

Items 801–900 of 1,015

  1. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia
    Bette C Liu, Duleepa Jayasundara, Victoria Pye, Timothy Dobbins, Gregory J. Dore, Gail V. Matthews, John Martin Kaldor, Paula Spokes · 2021 · The Lancet Regional Health - Western Pacific
  2. Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study
    Ujué Fresán, Marcela Guevara, Fernando Elía, Esther Albéniz, Cristina Burgui, Jesús Castilla, for the Working Group for the Study of COVID‐19 in Navarra · 2020 · Obesity
  3. Asthma and COVID-19: review of evidence on risks and management considerations
    Jamie Hartmann‐Boyce, James B. Gunnell, Jonny Drake, Afolarin A. Otunla, Jana Suklan, Ella Schofield, Jade Kinton, Matthew Inada-Kim, Richard F. Hobbs, Paddy Dennison · 2020 · BMJ Evidence-Based Medicine
  4. The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID‐19 infection: A case–control study of hospitalized patients in Tehran, Iran
    Alireza Abdollahi, Hasti Kamali Sarvestani, Zahra Rafat, Sara Ghaderkhani, Maedeh Mahmoodi Aliabadi, Bita Jafarzadeh, Vahid Mehrtash · 2020 · Journal of Medical Virology
  5. Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany
    Georg Fröhlich, Elke Jeschke, Uwe Eichler, Hölger Thiele, Laila Alhariri, Markus Reinthaler, Adnan Kastrati, David M. Leistner, Carsten Skurk, Ulf Landmesser et al. · 2021 · Clinical Research in Cardiology
  6. Variations in health behaviors among pregnant women during the COVID-19 pandemic
    Kara M. Whitaker, Peiyin Hung, Anthony J. Alberg, Nicole L. Hair, Jihong Liu · 2021 · Midwifery
  7. Associations between vaping and Covid-19: Cross-sectional findings from the HEBECO study
    Dimitra Kale, Aleksandra Herbeć, Olga Perski, Sarah E. Jackson, Jamie Brown, Lion Shahab · 2021 · Drug and Alcohol Dependence
  8. Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?
    Stephan Katzenschlager, A. Zimmer, Claudius Gottschalk, Juergen Grafeneder, Stephani Schmitz, Sara Kraker, Marlene Ganslmeier, Amelie Muth, Alexander Seitel, Lena Maier‐Hein et al. · 2021 · PLoS ONE
  9. Risk factors for hospitalization among persons with COVID-19—Colorado
    Grace M. Vahey, Emily Gibson McDonald, Kristen E. Marshall, Stacey W. Martin, Helen Chun, Rachel Herlihy, Jacqueline E. Tate, Breanna Kawasaki, Claire M. Midgley, Nisha B. Alden et al. · 2021 · PLoS ONE
  10. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
    Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara · 2021 · Viruses
  11. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
    Marijke Linschoten, Alicia Uijl, Astrid Schut, C E M Jakob, L R Romão, RM Bell, Ewan McFarlane, Melanie Stecher, Anna G M Zondag, Erik P.A. van Iperen et al. · 2021 · European Heart Journal
  12. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  13. Risk of mortality in COVID-19 patients: a meta- and network analysis
    Rasoul Kowsar, Amir Mohammad Rahimi, Magdalena Sroka, Alireza Mansouri, Khaled Sadeghi, Elham Bonakdar, Sayed Farshad Kateb, Amir Hossein Mahdavi · 2023 · Scientific Reports
  14. Total antioxidant capacity as a marker of severity of COVID‐19 infection: Possible prognostic and therapeutic clinical application
    Neda Yaghoubi, Masoud Youssefi, Farahzad Jabbari Azad, Faramarz Farzad, Zahra Yavari, Farnaz Zahedi Avval · 2021 · Journal of Medical Virology
  15. Body mass index and risk of obesity‐related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database
    Haase, Christiane L., Eriksen, Kirsten T., Lopes, Sandra, Satylganova, Altynai, Schnecke, Volker, McEwan, Phil · 2021 · Obesity Science & Practice
  16. Why lockdown of the elderly is not ageist and why levelling down equality is wrong
    Julian Savulescu, James Cameron · 2020 · Journal of Medical Ethics
  17. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications
    Christiaan J. Vrints, Konstantin Alexander Krychtiuk, Emeline M. Van Craenenbroeck, Vincent F. M. Segers, Susanna Price, Hein Heidbüchel · 2020 · Acta cardiologica. Supplementum
  18. Erhöhtes Risiko eines COVID-19-bedingten Krankenhausaufenthaltes für Arbeitslose: Eine Analyse von Krankenkassendaten von 1,28 Mio. Versicherten in Deutschland
    Morten Wahrendorf, Christoph J. Rupprecht, Olga Dortmann, Maria Scheider, Nico Dragano · 2021 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  19. Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
    Rebecca Nirmal Kumar, En‐Ling Wu, Valentina Stosor, William Justin Moore, Chad J. Achenbach, Michael G. Ison, Michael Angarone · 2021 · Clinical Infectious Diseases
  20. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae
    Stephanie M. LaVergne, Sophia Stromberg, Bridget A. Baxter, Tracy L. Webb, Taru S. Dutt, Kailey Berry, Madison Tipton, Jared Haberman, Benjamin R. Massey, Kim McFann et al. · 2021 · BMC Infectious Diseases
  21. Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors
    P. O. Baqui, Valerio Marra, Ahmed M. Alaa, Ioana Bica, Ari Ercole, Mihaela van der Schaar · 2021 · Scientific Reports
  22. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain
    Inés Suárez‐García, Isabel Perales-Fraile, Andrés González García, Arturo Muñoz Blanco, Luís Manzano, M. Fabregate, Jesús Díez‐Manglano, Eva Fonseca Aizpuru, Francisco Arnalich, Alejandra García García et al. · 2021 · PLoS ONE
  23. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
    Karin Welén, Ebba Rosendal, Magnus Gisslén, Annasara Lenman, Eva Freyhult, Osvaldo Fonseca‐Rodríguez, Daniel Bremell, Johan Stranne, Åse Östholm Balkhed, Katarina Niward et al. · 2021 · European Urology
  24. Biosecurity in an age of open science
    James Andrew Smith, Jonas B. Sandbrink · 2022 · PLoS Biology
  25. COVID-19-Related ARDS: Key Mechanistic Features and Treatments
    John Selickman, Charikleia S. Vrettou, Spyros D. Mentzelopoulos, John J. Marini · 2022 · Journal of Clinical Medicine
  26. Data capture and sharing in the COVID-19 pandemic: a cause for concern
    Louis Dron, Vinusha Kalatharan, Alind Gupta, Jonas Häggström, Névine M.-D. Zariffa, Andrew D. Morris, Paul Arora, Jay Park · 2022 · The Lancet Digital Health
  27. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
    Jatin Patel, Damon Bass, Albertus Beishuizen, Xavier Bocca Ruiz, Hatem Boughanmi, Anthony P. Cahn, Hugo R. Colombo, Gerard J. Criner, Katherine Davy, Javier de Miguel‐Díez et al. · 2022 · European Respiratory Journal
  28. COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry
    Samira Bell, Jacqueline Campbell, Jackie McDonald, Martin O’Neill, Chrissie Watters, Katharine Buck, Zoe Cousland, Mark Findlay, Nazir Lone, Wendy Metcalfe et al. · 2020 · BMC Nephrology
  29. Prevalence of antibodies against SARS-CoV-2 according to socioeconomic and ethnic status in a nationwide Brazilian survey
    Bernardo Lessa Horta, Mariângela Freitas da Silveira, Aluísio J. D. Barros, Fernando C. Barros, Fernando Pires Hartwig, Mariane da Silva Dias, Ana M. B. Menezes, Pedro Rodrigues Curi Hallal, Cesar Gomes Victora · 2020 · Revista Panamericana de Salud Pública
  30. Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data
    Helena Carreira, Helen Strongman, Maria Peppa, Helen I McDonald, Isabel dos‐Santos‐Silva, Susannah Jane Stanway, Liam L Smeeth, Krishnan Bhaskaran · 2020 · EClinicalMedicine
  31. Observational study of haloperidol in hospitalized patients with COVID-19
    Nicolas Hoertel, Marina Sánchez Rico, Raphaël Vernet, Anne‐Sophie Jannot, Antoine Neuraz, Carlos Blanco, Cédric Lemogne, Guillaume Airagnes, Nicolás Paris, Christel Daniel et al. · 2021 · PLoS ONE
  32. Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
    Roseanne E Billany, Haresh Selvaskandan, Sherna F. Adenwalla, Katherine Leigh Hull, Daniel S. March, James O. Burton, NICOLETTE CLAIRE BISHOP, Edward J Carr, Rupert C. L. Beale, Julian Wei-Tze Tang et al. · 2021 · Kidney International
  33. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients
    Aymric Kisserli, Nathalie Schneider, Sandra Audonnet, Thierry Tabary, Antoine Goury, Joël Cousson, Rachid Mahmoudi, Firouzé Bani‐Sadr, Lukshe Kanagaratnam, Damien Jolly et al. · 2021 · Immunobiology
  34. Asthma and COVID-19: a dangerous liaison?
    Carlo Lombardi, Federica Gani, Alvise Berti, Pasquale Comberiati, Diego Giampietro Peroni, Marcello Cottini · 2021 · Asthma Research and Practice
  35. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study
    Laurent Bailly, Roxane Fabre, Johan Courjon, Michel Carlès, Jean Dellamonica, Christian Pradier · 2021 · Clinical Microbiology and Infection
  36. Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
    Nils Jedicke, Metodi V. Stankov, Anne Cossmann, Alexandra Dopfer‐Jablonka, Christine Knuth, Gerrit Ahrenstorf, Gema Morillas Ramos, Georg M. N. Behrens · 2021 · HIV Medicine
  37. Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
    Yulia Alexandrova, Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2022 · Frontiers in Immunology
  38. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients
    Bart G. C. W. Pijls, Shahab Jolani, Anique Atherley, Janna I.R. Dijkstra, Gregor H. L. M. Franssen, Stevie Hendriks, Evan Yi-Wen Yu, Saurabh Zalpuri, Anke Richters, Maurice Petrus Zeegers · 2022 · F1000Research
  39. Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
    Marco Krasselt, Ulf G. Wagner, Phuong Nguyen, Corinna Pietsch, Andreas Boldt, Christoph Baerwald, Matthias Pierer, Olga Seifert · 2022 · Rheumatology
  40. The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: an international multicentre study
    Grace Wei, Janine Diehl‐Schmid, Jordi A. Matías‐Guiu, Yolande A.L. Pijnenburg, Ramón Landín-Romero, Hans Bogaardt, Olivier Piguet, Fiona Kumfor · 2022 · Scientific Reports
  41. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table
    Francesco Cosentino, Subodh Verma, Phil Ambery, Marianne Bach Treppendahl, Martin van Eickels, Stefan D. Anker, Michele Cecchini, Paola Fioretto, Per‐Henrik Groop, David A. Hess et al. · 2023 · European Heart Journal
  42. Causes and costs of global COVID-19 vaccine inequity
    Maddalena Ferranna · 2023 · Seminars in Immunopathology
  43. Interpreting, analysing and modelling COVID-19 mortality data
    Didier Sornette, Euan W. Mearns, Michael Schatz, Ke Wu, Didier Darcet · 2020 · Nonlinear Dynamics
  44. Assessment of the effect of the COVID‐19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring
    Anna R. Dover, Stuart A. Ritchie, John A. McKnight, Mark W. J. Strachan, Nicola N. Zammitt, Deborah Jane Wake, Shareen Forbes, Roland H. Stimson, Fraser W. Gibb · 2020 · Diabetic Medicine
  45. Black Lives Matter in health promotion: moving from unspoken to outspoken
    Stephanie Leitch, J. Hope Corbin, Nikita Boston-Fisher, Christa Ayele, Peter Delobelle, Fungisai Gwanzura Ottemöller, Tulani Francis L. Matenga, Oliver Mweemba, Ann Pederson, Josette Wicker · 2020 · Health Promotion International
  46. The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19
    Cathy A. Goldstein, Muneer Rizvydeen, Deirdre A. Conroy, Louise Margaret O'Brien, Gita Gupta, Emily C. Somers, Pratima Sharma, Jonathan L. Golob, Jonathan P. Troost, Helen J. Burgess · 2021 · Journal of Clinical Sleep Medicine
  47. SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients
    Alexandre Favà, Laura Donadeu, Núria Sabé, Vincent Pernin, José González‐Costello, Laura Lladó, María Meneghini, Xavier Charmetant, Elena García‐Romero, Alba Cachero et al. · 2021 · American Journal of Transplantation
  48. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
    Eng Hooi Tan, Anthony G. Sena, Albert Prats‐Uribe, Seng Chan You, Waheed‐Ul‐Rahman Ahmed, Kristin Kostka, Christian Reich, Scott L. DuVall, Kristine E. Lynch, Michael Edwin Matheny et al. · 2021 · Rheumatology
  49. COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
    Tom Børge Johannesen, Sigbjørn Smeland, Stein Aaserud, Eirik Alnes Buanes, Anna Skog, Giske Ursin, Åslaug Helland · 2021 · Frontiers in Oncology
  50. Precision therapeutic targets for COVID-19
    Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd Eliot Golde, Benoit I. Giasson, Yuxing Xia · 2021 · Virology Journal
  51. Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank
    Ruth Topless, Amanda J. Phipps‐Green, Megan Leask, Nicola Dalbeth, Lisa K. Stamp, Philip Cameron Robinson, Tony Raymond Merriman · 2021 · ACR Open Rheumatology
  52. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study
    M. Heldman, O. Kates, K. Safa, C. Kotton, Sarah J Georgia, J. Steinbrink, B. Alexander, M. Hemmersbach-Miller, E. Blumberg, M. Crespo et al. · 2021 · American Journal of Transplantation
  53. Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study
    Julian W. Sacre, Elizabeth Holmes‐Truscott, Agus Salim, Kaarin Jane Anstey, Grant Raymond Drummond, Rachel Huxley, Dianna J. Magliano, Peter van Wijngaarden, Paul Zimmet, Jane Speight et al. · 2021 · Diabetic Medicine
  54. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
    Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Émilie Delattre et al. · 2021 · Frontiers in Public Health
  55. The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
    Amar Sarkar, Siobhán Harty, Andrew H. Moeller, Sabra L. Klein, Susan E. Erdman, Karl John Friston, Rachel N. Carmody · 2021 · Trends in Molecular Medicine
  56. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
    Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, Nareshkumar Poopalasingam, Matthijs Meijers, Christoph Kreer, Franziska Kleipass, Denis Ruchnewitz, Meryem Seda Ercanoglu, Henning Gruell et al. · 2021 · Cell Host & Microbe
  57. Extracorporeal membrane oxygenation in coronavirus disease 2019
    Benjamin Friedrichson, Jan A. Kloka, Vanessa Neef, Haitham Mutlak, Oliver Old, Kai Zacharowski, Florian Piekarski · 2022 · European Journal of Anaesthesiology
  58. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
    Luke R. Bonser, Walter L. Eckalbar, Lauren Rodriguez, Jiangshan Jane Shen, Kyung Duk Koh, Khadija Ghias, Lorna T. Zlock, Stephanie A. Christenson, Prescott G. Woodruff, Walter E. Finkbeiner et al. · 2022 · American Journal of Respiratory Cell and Molecular Biology
  59. Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
    Lisa Loksø Dietz, Anna Karina Juhl, Ole Schmeltz Søgaard, Joanne Reekie, Henrik Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Tomas Østergaard Jensen et al. · 2023 · Communications Medicine
  60. Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters
    Lou Delval, Aline Hantute-Ghesquier, Valentin Sencio, Jean‐Michel Flaman, Cyril Robil, Fabiola Silva Angulo, Larissa Lipskaia, Özmen Çobanoglu, Anne‐Sophie Lacoste, Arnaud Machelart et al. · 2023 · Nature Aging
  61. On the importance of primary and community healthcare in relation to global health and environmental threats: lessons from the COVID-19 crisis
    Paolo Lauriola, Piedad Martín‐Olmedo, Giovanni Sebastiano Leonardi, Catherine Bouland, Robert A. Verheij, Michel Dückers, Martie van Tongeren, Ferdinando Laghi, Peter van den Hazel, Özden Gökdemir et al. · 2021 · BMJ Global Health
  62. The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction
    Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, Benjamin Amor, Adit Anand, Mark M. Bissell, Katie R. Bradwell, Carolyn Bremer, James Brian Byrd, Alina Denham et al. · 2021 · medRxiv
  63. COVID-19: Situation of European Countries so Far
    Sunitha Pillai, Nazeeba Siddika, Ehsanul Hoque Apu, Russell Kabir · 2020 · Archives of Medical Research
  64. Risk factors for death from COVID-19
    Myvizhi Esai Selvan · 2020 · Nature reviews. Immunology
  65. Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)
    V. Yu. Mareev, Yа. A. Orlova, Е.П. Павликова, С.Т. Мацкеплишвили, Tatyana N. Krasnova, П. С. Малахов, Larisa Mikhailovna Samokhodskaya, Elena A. Mershina, Valentin E. Sinitsyn, Yu. V. Mareev et al. · 2020 · Kardiologiia
  66. Public health rationale for reducing sugar: Strategies and challenges
    Sara A. Stanner, Ayela Spiro · 2020 · Nutrition Bulletin
  67. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico
    Orison O. Woolcott, Juan P. Castilla-Bancayán · 2021 · Scientific Reports
  68. Insights into SARS-CoV-2 Persistence and Its Relevance
    Belete Ayele Desimmie, Yonas Raru, Hesham Awadh, Peimei He, Samson Teka, Kara S. Willenburg · 2021 · Viruses
  69. Elevated HbA1c levels in pre‐Covid‐19 infection increases the risk of mortality: A systematic review and meta‐analysis
    Francesco Prattichizzo, Paola de Candia, Antonio Nicolucci, Antonio Ceriello · 2021 · Diabetes/Metabolism Research and Reviews
  70. Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities
    Marcel Ballin, Jonathan Bergman, Miia Kivipelto, Anna Nordström, Peter Nordström · 2021 · Journal of the American Medical Directors Association
  71. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
    Evgeny Lvovich Nasonov, Aleksander M. Lila, Mazurov Vi, Boris Sergeyevich Belov, Andrey E. Karateev, Т. В. Дубинина, O. A. Nikitinskaya, Andrey A. Baranov, Diana Ildarovna Abdulganieva, Sergey Valentinovich Moiseev et al. · 2021 · Rheumatology Science and Practice
  72. Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
    Donato Lacedonia, Giulia Scioscia, Carla Santomasi, Paolo Fuso, Giovanna Elisiana Carpagnano, Andrea Portacci, Franco Mastroianni, Giovanni Larizza, Eugenio Sabato, Emanuela Profilo et al. · 2021 · Scientific Reports
  73. Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients
    Rasoul Abdollahzadeh, Mohammad Hossein Shushizadeh, Mina Barazandehrokh, Sepideh Choopani, Asaad Azarnezhad, Sahereh Paknahad, Maryam Pirhoushiaran, S. Zahra Makani, Razieh Zarifian Yeganeh, Ahmed Al-Kateb et al. · 2021 · Infection Genetics and Evolution
  74. Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19
    Ho Namkoong, Ryuya Edahiro, Koichi Fukunaga, Yuya Shirai, Kyuto Sonehara, Hiromu Tanaka, Ho Lee, Takanori Hasegawa, Kanai Masahiro, Tatsuhiko Naito et al. · 2021 · International Journal of Infectious Diseases
  75. Socioeconomic deprivation and ethnicity inequalities in disruption to NHS hospital admissions during the COVID-19 pandemic: a national observational study
    Max Warner, Samantha L Burn, George Stoye, Paul P Aylin, Alex Bottle, Carol Propper · 2021 · BMJ Quality & Safety
  76. A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England
    Thomas E. Yates, Annabel Summerfield, Cameron Razieh, Amitava Banerjee, Yogini Chudasama, Melanie Jane Davies, Clare L. Gillies, Nazrul Islam, Claire Alexandra Lawson, Evgeny M. Mirkes et al. · 2022 · Nature Communications
  77. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
    Lívia Teixeira, Jairo Ramos Temerozo, Filipe Santos Pereira-Dutra, André Costa Ferreira, Mayara Mattos, Barbara Simonson Gonçalves, Carolina Q. Sacramento, Lohanna Palhinha, Tamires Cunha‐Fernandes, Suelen da Silva Gomes Dias et al. · 2022 · Frontiers in Immunology
  78. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel
    Nitzan Krinsky, Sofia Sizikov, Sivan Nissim, Adi Dror, Anna Sas, Hodaya Prinz, Ester Pri-Or, Shay Perek, Ayelet Raz‐Pasteur, Izabella Lejbkowicz et al. · 2023 · Journal of Thrombosis and Haemostasis
  79. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database
    Daniel Schönfeld, Sergio Arias, Juan Carlos Bossio, Hugo Fernando Fernández, David Gozal, Daniel Pérez-Chada · 2021 · PLoS ONE
  80. Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19
    Chuang Guo, Mingming Wu, Beibei Huang, Rui Zhao, Linlin Jin, Binqing Fu, Ping Wang, Dongyao Wang, Meijuan Zheng, Jingwen Fang et al. · 2022 · Genome Medicine
  81. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
    Jamie Nicole Justice, Sriram Gubbi, Ameya S Kulkarni, Jenna M. Bartley, George A. Kuchel, Nir Barzilai · 2020 · GeroScience
  82. Infections and diabetes: Risks and mitigation with reference to India
    Ranjit Unnikrishnan I, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  83. Covid-19 and rural landscape: The case of Italy
    Mauro Agnoletti, Simone Manganelli, Francesco Piras · 2020 · Landscape and Urban Planning
  84. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
    Jon Hazeldine, Janet M. Lord · 2020 · Frontiers in Immunology
  85. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff
    Christopher Andrew Martin, Prashanth Patel, Charles Goss, David R. Jenkins, Arthur Price, Linda M Barton, Pankaj Gupta, Francesco Zaccardi, Helen Jerina, Sai Duraisingham et al. · 2020 · Journal of Public Health
  86. Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic
    Emily J. Peach, Megan Rutter, Peter Lanyon, Matthew J. Grainge, Richard Hubbard, Jeanette Aston, Mary Bythell, Sarah C. W. Stevens, Fiona Pearce · 2020 · Rheumatology
  87. Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
    Shannon Wongvibulsin, Brian Thomas Garibaldi, Annukka A.R. Antar, Jiyang Wen, Mei‐Cheng Wang, Amita Gupta, Robert C. Bollinger, Yanxun Xu, Kunbo Wang, Joshua Betz et al. · 2021 · Annals of Internal Medicine
  88. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review
    Vijay Viswanathan, Anudeep Puvvula, Ankush D. Jamthikar, Luca Saba, Amer M. Johri, Vasilios Kotsis, Narendra Nath Khanna, Surinder K. Dhanjil, Misha Majhail, Durga Prasanna Misra et al. · 2021 · World Journal of Diabetes
  89. Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance
    Geeta Hampson, Mike D. Stone, J. R. Lindsay, Rachel Katherine Crowley, Stuart H. Ralston · 2021 · Calcified Tissue International
  90. Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
    Saúl Reyes, Anthony Lawrence Cunningham, Tomáš Kalinčík, Eva Havrdová, Noriko Isobe, Julia Pakpoor, Laura M. Airas, Reem Fahd Bunyan, Anneke van der Walt, Jiwon Oh et al. · 2021 · Journal of Neuroimmunology
  91. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
    Deepali Kumar, Victor H. Ferreira, Victoria G. Hall, Queenie Hu, Reuben Samson, Terrance Ku, Matthew Ierullo, Beata Majchrzak-Kita, George Tomlinson, Anne‐Claude Gingras et al. · 2021 · Annals of Internal Medicine
  92. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
    The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · Cardiovascular Research
  93. Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors
    Shuhei Nomura, Haruka Sakamoto, Cyrus Ghaznavi, Manami Inoue · 2022 · The Lancet Regional Health - Western Pacific
  94. RETRACTED: A hierarchical multi-leadership sine cosine algorithm to dissolving global optimization and data classification: The COVID-19 case study
    Mingyang Zhong, Jiahui Wen, Jingwei Ma, Hao Cui, Qiuling Zhang, Morteza Karimzadeh Parizi · 2023 · Computers in Biology and Medicine · Retracted
  95. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
    Elsa Brunet‐Ratnasingham, Sai Priya Anand, Pierre Gantner, Alina Dyachenko, Gaël Moquin‐Beaudry, Nathalie Brassard, Guillaume Beaudoin-Bussières, Amélie Pagliuzza, Romain Gasser, Mehdi Benlarbi et al. · 2021 · Science Advances
  96. Sex differences in the case-fatality rates for COVID-19—A comparison of the age-related differences and consistency over seven countries
    Green, Manfred S., Nitzan, Dorit, Schwartz, Naama, Niv, Yaron, Peer, Victoria · 2021 · PLOS ONE
  97. Forecasting the Spreading of COVID-19 across Nine Countries from Europe, Asia, and the American Continents Using the ARIMA Models
    Ovidiu‐Dumitru Ilie, Roxana-Oana Cojocariu, Alin Stelian Ciobica, Sergiu-Ioan Timofte, Ioannis Asterios Mavroudis, Bogdan Doroftei · 2020 · Microorganisms
  98. Impact of Right Ventricular Dysfunction on Mortality in Patients Hospitalized With COVID-19, According to Race
    William Edward Moody, Hani M. Mahmoud-Elsayed, Jonathan Senior, Uzma Javed Gul, Ayisha Mehtab Khan‐Kheil, Sebastian Horne, Amitava Banerjee, William M. Bradlow, Robert Huggett, Sandeep Singh Hothi et al. · 2020 · CJC Open
  99. Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment
    Nizam Mamode, Zubir Ahmed, GARETH LLOYD JONES, Neal R. Banga, Reza Motallebzadeh, Hannah Tolley, Steve Marks, Jelena Stojanović, Muhammad Arslan Khurram, Raj C. Thuraisingham et al. · 2020 · Transplantation
  100. COVID-19 in Chronic Liver Disease and Liver Transplantation
    Abdul Mohammed, Neethi Paranji, Po‐Hung Chen, Bolin Niu · 2020 · Journal of Clinical Gastroenterology